Brainstorm Cell Therapeutics (BCLI) Stock Chart & Stock Price History → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free BCLI Stock Alerts $0.53 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Brainstorm Cell Therapeutics Stock Price Performance5 Day Performance-1.04%1 Month Performance-10.95%3 Month Performance+68.61%6 Month Performance+234.06%Year-To-Date Performance+95.79%1 Year Performance-81.51% Receive BCLI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. BCLI Stock Chart for Saturday, April, 27, 2024 BCLI Chart by TradingView Brainstorm Cell Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$0.53$0.53+0.47%$0.56$0.52265,170 shs$36.53 million04/25/2024$0.55$0.53-2.39%$0.56$0.52273,815 shs$36.36 million04/24/2024$0.53$0.55+3.81%$0.56$0.52201,562 shs$37.25 million04/23/2024$0.54$0.53-2.80%$0.56$0.51166,413 shs$35.88 million04/22/2024$0.53$0.54+1.52%$0.58$0.52365,604 shs$36.91 million04/19/2024$0.51$0.53+3.44%$0.61$0.451.01 million shs$36.36 million Get the Latest News and Ratings for BCLI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$0.54$0.51-4.90%$0.59$0.451.08 million shs$35.15 million04/17/2024$0.53$0.54+2.60%$0.59$0.53528,793 shs$36.96 million04/16/2024$0.55$0.53-3.94%$0.57$0.45622,189 shs$36.02 million04/15/2024$0.58$0.55-6.04%$0.60$0.54589,469 shs$37.50 million04/12/2024$0.58$0.58+1.20%$0.62$0.58263,963 shs$39.91 million04/11/2024$0.60$0.58-4.06%$0.67$0.541.39 million shs$39.44 million04/10/2024$0.58$0.60+3.26%$0.64$0.581.10 million shs$41.11 million04/09/2024$0.73$0.58-20.21%$0.74$0.574.71 million shs$39.81 million04/08/2024$0.65$0.73+12.14%$0.75$0.652.59 million shs$49.89 million04/05/2024$0.68$0.65-3.56%$0.69$0.63623,369 shs$31.89 million04/04/2024$0.69$0.68-2.07%$0.72$0.65713,516 shs$33.06 million04/03/2024$0.72$0.69-4.13%$0.72$0.67942,014 shs$33.76 million04/02/2024$0.74$0.72-2.82%$0.75$0.67600,184 shs$35.22 million04/01/2024$0.56$0.74+31.03%$0.75$0.591.43 million shs$36.24 million03/29/2024$0.56$0.56$0.60$0.48649,965 shs$27.66 million03/28/2024$0.60$0.56-5.91%$0.60$0.49647,340 shs$27.66 million03/27/2024$0.66$0.60-9.06%$0.69$0.511.28 million shs$29.40 million03/26/2024$0.66$0.66+0.76%$0.72$0.621.49 million shs$32.33 million03/25/2024$0.57$0.66+14.91%$0.79$0.574.64 million shs$32.08 million03/22/2024$0.48$0.57+18.75%$0.58$0.471.77 million shs$27.92 million03/21/2024$0.51$0.48-5.33%$0.56$0.401.80 million shs$23.51 million03/20/2024$0.36$0.51+42.54%$0.55$0.364.40 million shs$24.83 million03/19/2024$0.33$0.36+8.31%$0.37$0.33656,523 shs$17.42 million03/18/2024$0.33$0.33-1.35%$0.34$0.33361,486 shs$16.09 million03/15/2024$0.33$0.33+1.31%$0.34$0.33449,409 shs$16.31 million03/14/2024$0.33$0.33-0.60%$0.35$0.33325,171 shs$16.10 million03/13/2024$0.31$0.33+7.30%$0.36$0.32679,769 shs$16.19 million03/12/2024$0.33$0.31-6.35%$0.33$0.27231,754 shs$15.09 million03/11/2024$0.33$0.33-0.30%$0.34$0.32343,760 shs$16.11 million03/08/2024$0.35$0.33-5.15%$0.35$0.33405,177 shs$16.16 million03/07/2024$0.33$0.35+5.55%$0.35$0.32495,768 shs$17.04 million03/06/2024$0.35$0.33-5.34%$0.34$0.33242,466 shs$16.14 million03/05/2024$0.37$0.35-4.60%$0.37$0.321.84 million shs$17.06 million03/04/2024$0.35$0.37+5.74%$0.37$0.32399,491 shs$17.88 millionProtect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late.03/01/2024$0.37$0.35-5.94%$0.37$0.34194,303 shs$16.91 million02/29/2024$0.37$0.37+0.11%$0.38$0.341.52 million shs$17.98 million02/28/2024$0.36$0.37+0.99%$0.37$0.35446,381 shs$17.96 million02/27/2024$0.36$0.36+1.14%$0.38$0.34744,600 shs$17.78 million02/26/2024$0.35$0.36+2.84%$0.37$0.312.49 million shs$17.58 million02/23/2024$0.33$0.35+5.60%$0.38$0.33506,731 shs$17.09 million02/22/2024$0.31$0.33+6.27%$0.34$0.32233,125 shs$16.19 million02/21/2024$0.36$0.31-13.61%$0.36$0.30867,661 shs$15.23 million02/20/2024$0.37$0.36-3.67%$0.38$0.34217,721 shs$17.63 million02/19/2024$0.37$0.37$0.38$0.34206,700 shs$18.30 million02/16/2024$0.39$0.37-3.69%$0.38$0.34206,773 shs$18.30 million02/15/2024$0.35$0.39+11.17%$0.39$0.33532,076 shs$19.00 million02/14/2024$0.34$0.35+4.18%$0.36$0.311.98 million shs$17.09 million02/13/2024$0.36$0.34-5.63%$0.37$0.32632,550 shs$16.41 million02/12/2024$0.38$0.36-5.33%$0.38$0.36288,018 shs$17.39 million02/09/2024$0.39$0.38-4.31%$0.39$0.36343,655 shs$18.37 million02/08/2024$0.38$0.39+2.06%$0.40$0.331.15 million shs$19.20 million02/07/2024$0.39$0.38-1.29%$0.39$0.32655,469 shs$18.81 million02/06/2024$0.38$0.39+2.37%$0.41$0.38334,080 shs$19.05 million02/05/2024$0.39$0.38-2.56%$0.40$0.38452,986 shs$18.61 million02/02/2024$0.39$0.39+1.30%$0.41$0.331.88 million shs$19.10 million02/01/2024$0.35$0.39+8.97%$0.39$0.35537,571 shs$18.86 million01/31/2024$0.39$0.35-10.22%$0.40$0.35767,913 shs$17.31 million01/30/2024$0.33$0.39+19.24%$0.42$0.352.73 million shs$19.27 million01/29/2024$0.32$0.33+4.10%$0.35$0.31536,515 shs$16.16 million01/26/2024$0.31$0.32+2.19%$0.33$0.30552,099 shs$15.53 million Related Companies: CYTH Stock Chart TARA Stock Chart ESLA Stock Chart INAB Stock Chart CRTX Stock Chart ACHL Stock Chart OKYO Stock Chart SABS Stock Chart INKT Stock Chart NKGN Stock Chart Receive BCLI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BCLI) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsJeff Bezos Just Humiliated Elon MuskInvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsMan Who Predicted 2008: “This Will be Worse.”AltimetryYou Won't Believe Who Bezos is Working With to Fight Alzheimer'sBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainstorm Cell Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.